SCHEMBL23051981

SCHEMBL23051981

CCC(=O)N[C@@H](COC(C)(C)C)C(=O)OC(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRN P28799 1/20 0.40
▸ SORT1 Q99523 1/20 0.40
▸ BACE1 P56817 2/20 0.36
▸ CYP2C9 P11712 2/20 0.35
▸ MAPK14 Q16539 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ MAPK1 P28482 1/20 0.34
▸ CTSK P43235 7/20 0.34
▸ CTSS P25774 3/20 0.34
▸ CAPN1 P07384 1/20 0.34
▸ POLB P06746 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ CTSL P07711 1/20 0.33
▸ CTSB P07858 1/20 0.33
▸ CA1 P00915 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ CA7 P43166 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23051973 0.83 GRN (0.39) GRNSORT1CYP2C9CYP1A2CYP2C19
SCHEMBL23332621 0.81 SERPINE1 (0.39) GRNSORT1CTSKCTSSCAPN1
SCHEMBL29750396 0.81 CAD (0.39) GRNSORT1BACE1CYP2C9MAPK14
SCHEMBL4808053 0.80 GRN (0.36) GRNSORT1BACE1MAPK14MAPK1
SCHEMBL4808040 0.80 GRN (0.36) GRNSORT1BACE1MAPK14MAPK1
SCHEMBL23051872 0.80 CTSK (0.38) GRNSORT1MAPK1CTSKCTSS
SCHEMBL30826518 0.80 CYP2D6 (0.42) CYP2C9CYP1A2CYP2C19HTTCTSK
SCHEMBL25455581 0.79 MAPK1 (0.36) GRNSORT1CYP2C9MAPK14CYP1A2
SCHEMBL20571234 0.79 GRN (0.40) GRNSORT1BACE1CYP2C9MAPK14
SCHEMBL20571233 0.79 GRN (0.40) GRNSORT1BACE1CYP2C9MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021038426-A1 SUBSTITUTED 1,3-PHENYL HETEROARYL DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE NOVARTIS AG (CH) 2021-03-04 — — WO disclosed
Send feedback